Medications
FDA-approved GLP-1s
Monthly Cost
$49 one-time application/screening fee + medication/program pricing varies
Speed to Start
Fast
Est. 2020
About eMed
eMed entered the telehealth space in 2020 and quickly gained recognition during the COVID-19 pandemic for its at-home testing infrastructure. The company has since pivoted that diagnostic capability into clinical weight management, offering FDA-approved GLP-1 medications through a structured program that begins with a screening fee, with ongoing medication costs varying by prescription. Unlike many competitors that rely on compounded formulations, eMed’s commitment to FDA-approved medications positions it as a more clinically conservative option in the telehealth weight loss market.
On Trustpilot, eMed holds a 4.0 rating across 260+ reviews, a respectable score that reflects generally positive patient experiences. The company also carries an A rating with the BBB, indicating strong complaint resolution practices and business transparency. Together, these metrics paint a picture of a trustworthy operation, even if the Trustpilot volume is lower than some larger competitors.
eMed’s clinical differentiator is its at-home blood testing capability, a direct inheritance from its pandemic-era diagnostics platform. Patients receive testing kits shipped to their homes, eliminating the need for lab visits and reducing friction in the onboarding process. This is a high-support model that includes regular provider check-ins, metabolic monitoring, and structured treatment protocols. The company also offers employer-sponsored programs, making it one of the few GLP-1 telehealth providers accessible through workplace health benefits — a significant cost advantage for eligible patients.
The FDA-approved-only medication policy is both a strength and a limitation. Patients who prioritize regulatory certainty and want medications with full FDA oversight will appreciate eMed’s approach. However, this also means pricing may be higher than compounded alternatives, and patients without insurance coverage for brand-name GLP-1s could face substantial out-of-pocket costs. The screening fee is among the lowest initial consultation costs in the industry, but the total monthly cost depends heavily on which medication is prescribed and whether insurance or employer sponsorship applies.
eMed is a provider that rewards patients willing to navigate its somewhat variable pricing structure. The clinical infrastructure is strong, the at-home testing is genuinely convenient, and the employer-sponsored pathway can make FDA-approved GLP-1 therapy accessible at costs that would otherwise be prohibitive. For patients with straightforward budgets who want predictable monthly costs, the variable pricing model may be frustrating — but for those with employer health benefits or insurance coverage, eMed can deliver premium care at reduced personal expense.
eMed GLP-1 Medications
What the eMed Intake Looks Like
We walked through eMed’s full GLP-1 weight-loss intake ourselves — from the first consent screen through the medication-selection checkout. Here’s what an actual prospective patient encounters.
/ 10
The questionnaire collects only consent, DOB, and sex — three questions before checkout. No BMI, allergy, comorbidity, mental-health, eating-disorder, family-history, or FDA black-box (MTC/MEN2) screens are visible. eMed deliberately moves clinical screening to the at-home blood test + clinician review that follows the $49 commit, so the public-facing rigor is intentionally low.
/ 10
Moderate. The questionnaire is the fastest in our coverage, but you must commit $49 (non-refundable) for the At-Home Blood Test Kit before knowing if you’ll qualify. Medication and membership ($149/mo each + $10 shipping) are deferred until lab review, with a refund if you’re declined.
The 4 Stages
Clinical Safety Screens Performed (in the public questionnaire)
No BMI capture, no FDA black-box screen for MTC / MEN2, no validated PHQ-2 or PHQ-9, no dedicated eating-disorder screen, no allergy check, no comorbidity multi-select, no family medical history, no medication interaction screen, and no state-availability check are visible in the questionnaire. eMed’s safety net is the at-home blood test + downstream clinician review — but that occurs only after you commit $49, which means contraindications are surfaced post-payment rather than gated up-front.
Due today at checkout: $49 At-Home Blood Test Kit (one-time, non-refundable; includes the telehealth consultation). After lab results are reviewed: Wegovy Pill from $149/mo (higher doses up to $299/mo per the screenshot footnote), $149/mo eMed Membership, and $10 shipping are billed. If you’re not approved, the medication, membership, and shipping charges are fully refunded within 3-5 business days; the $49 lab kit is not refunded. Insurance is not the primary path here — eMed’s offer is structured around cash pay, with employer-sponsored programs available as an alternative on certain plans.
Source: GLP-1.Reviews editorial walkthrough on April 26, 2026. We completed every observable screen of the eMed weight-loss intake and stopped before submitting the $49 At-Home Blood Test Kit charge.
At a Glance
Medications Offered
FDA-approved GLP-1s
Both
Cost & Insurance
- Monthly: $49 one-time application/screening fee + medication/program pricing varies
- 6-month estimate: $1,194-$2,394
- Insurance: Employer-sponsored / program-based
- Self-pay: Unclear for broad direct-to-consumer use
Clinical Features
- Lab testing: Yes (at-home blood test in screening)
- Dietitian access: No
- Verified Pharmacy: FDA-approved medications focus; at-home testing partner; pharmacy fulfillment through employer programs
- BBB Rating: A
Delivery & Access
- Format: Subcutaneous
- Nationwide telehealth: Yes
- Speed: Fast
- Spanish-speaking providers: Not available
Begin with eMed’s $49 At-Home Blood Test Kit — Wegovy is prescribed after lab review and clinician approval
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.
Editorial Independence: GLP-1.Reviews maintains full editorial independence. Our scores are based on verified data and standardized criteria.
